Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 3, 2000, Pages 845-851

  Katz, Stuart D ^a   Balidemaj, Kujtim ^a   Homma, Shunichi ^b   Wu, Henry ^b   Wang, Jie ^a   Maybaum, Simon ^a  

^a Department of Orthopaedic Surgery   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC GMP; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PHOSPHODIESTERASE INHIBITOR; PLACEBO; SILDENAFIL;

ARTERY OCCLUSION; ARTICLE; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG MECHANISM; ECHOGRAPHY; FEMALE; HEART FAILURE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR SMOOTH MUSCLE; VASODILATATION;

BLOOD CIRCULATION; BLOOD FLOW VELOCITY; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; REFERENCE VALUES; VASODILATION;

EID: 0033858827     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00790-7     Document Type: Article

References (38)

1. Regulatory functions of the vascular endothelium
2. Nitric oxide: Physiology, pathophysiology and pharmacology
3. Endothelium-dependent vasodilation is attenuated in patients with heart failure
4. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: Role of endothelium-derived nitric oxide
5. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure
6. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
7. Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease
8. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure
9. Cyclic GMP and mechanisms of vasodilation
10. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
11. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
12. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
13. Sildenafil, a novel effective oral therapy for male erectile dysfunction
14. Oral sildenafil in the treatment of erectile dysfunction
15. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound
16. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
17. Effects of sildenafil citrate on human hemodynamics
18. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function and the contractile responses of trabeculae carneae and aortic rings in vitro
19. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
20. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog
21. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor
22. Analysis of responses to bradykinin in the pulmonary vascular bed of the cat
23. L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilation in lambs
24. T-kinin has endothelium-dependent vasodilator activity in the cat
25. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
26. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
27. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
28. Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure
29. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors
30. Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure
31. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent
32. Randomized, double-blind, placebo-controlled trial of supplemental oral L-arginine in patients with heart failure
33. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure
34. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation
35. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
36. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators
37. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease
38. Overall cardiovascular profile of sildenafil citrate